Back

Sirolimus-coated versus paclitaxel-coated balloons in the treatment of coronary lesions: a systematic review and meta-analysis

20 February 2026 (12:00 - 13:00)
Organised by: Logo
Congress Presentation Part of: Poster session (2) - Interventional cardiology (4) Devices EAPCI Premium Access EAPCI Summit 2026 European Association of Percutaneous Cardiovascular Interventions (EAPCI)

About the speaker

Photo
Doctor Ahmed Hegazy

Medway NHS Foundation Trust, Gillingham (United Kingdom of Great Britain & Northern Ireland)

7 More presentations in this session

Presentation thumbnail
Doctor B. Shah (Mumbai, IN)
Abstract Slides
Presentation thumbnail
Doctor D. Castiello (Rende, IT)
Abstract Slides
Presentation thumbnail
Doctor H. Rai (Dublin 7, IE)
Abstract Slides
Presentation thumbnail
Doctor C. Shih (Kaohsiung, TW)
Abstract
Presentation thumbnail
Doctor F. Oliveri (Leiden, NL)
Abstract Slides

Access the full session

Session thumbnail
Poster session (2) - Interventional cardiology (4)

The Event

Event poster

EAPCI Summit 2026

20 February 2026 12:00 CET
You may be interested in
thumbnail
Congress Presentation
Head to head comparison of limus vs paclitaxel-coated balloons (DCBs) in the treatment of in-stent restenosis: a meta-analysis
thumbnail
Congress Presentation
A novel sirolimus-coated balloon versus a paclitaxel-coated balloon for coronary artery disease: the SELSEQ registry
thumbnail
Congress Presentation
Biolimus-coated balloon or sirolimus-coated balloon vs paclitaxel-coated balloon for in-stent restenosis: a systematic review and meta-analysis

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources